Company Data
Outlook Therapeutics Inc.
Ticker
OTLK
Current Price
$1.125 3.21%
Market Cap
$50.0M
Price Target
Refer to Report
Volume
2.3M
52wk Range
$0.79 - $7.85
Overview
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.